SCYNEXIS, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
SCYNEXIS, Inc. (SCYX) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 635.55 thousand shares as of 2015-12-31, per its 10-K filed 2016-03-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2016-03-07
- 2015-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 635.55K shares.
- 2014-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 192.92K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2015-12-31 | 635.55K shares 10-K · filed 2016-03-07 |
| 2014-12-31 | 192.92K shares 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |